Signaling pathways and microRNAs, the orchestrators of NANOG activity during cancer induction.


Journal

Life sciences
ISSN: 1879-0631
Titre abrégé: Life Sci
Pays: Netherlands
ID NLM: 0375521

Informations de publication

Date de publication:
01 Nov 2020
Historique:
received: 08 07 2020
revised: 18 08 2020
accepted: 20 08 2020
pubmed: 26 8 2020
medline: 11 11 2020
entrez: 26 8 2020
Statut: ppublish

Résumé

Cancer stem cells (CSCs) are a small part of cancer cells inside the tumor that have similar characteristics to normal stem cells. CSCs stimulate tumor initiation and progression in a variety of cancers. Several transcription factors such as NANOG, SOX2, and OCT4 maintain the characteristics of CSCs and their upregulation is seen in many malignancies resulting in increased metastasis, invasion, and recurrence. Among these factors, NANOG plays an important role in regulating the self-renewal and pluripotency of CSCs and the clinical significance of NANOG has been suggested as a marker of CSCs in many cancers. The up and down-regulation of NANOG is associated with several important signaling pathways, including JAK/STAT, Wnt/β-catenin, Notch, TGF-β, Hedgehog, and several microRNAs (miRNAs). In this review, we will investigate the function of NANOG in CSCs and the molecular mechanism of its regulation by signaling pathways and miRNAs. We will also investigate targeting NANOG with different techniques, which is a promising treatment strategy for cancer treatment.

Identifiants

pubmed: 32841661
pii: S0024-3205(20)31089-4
doi: 10.1016/j.lfs.2020.118337
pii:
doi:

Substances chimiques

MicroRNAs 0
NANOG protein, human 0
Nanog Homeobox Protein 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

118337

Informations de copyright

Copyright © 2020 Elsevier Inc. All rights reserved.

Auteurs

Hajar Alemohammad (H)

Department of Biology, Faculty of Natural Sciences, University of Tabriz, Tabriz, Iran.

Zahra Asadzadeh (Z)

Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.

Rohollah Motafakker Azad (R)

Department of Plant Biology, Faculty of Natural Science, University of Tabriz, Iran.

Nima Hemmat (N)

Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.

Basira Najafzadeh (B)

Department of Biology, Faculty of Natural Sciences, University of Tabriz, Tabriz, Iran.

Parisa Vasefifar (P)

Department of Biology, Faculty of Natural Sciences, University of Tabriz, Tabriz, Iran.

Souzan Najafi (S)

Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.

Behzad Baradaran (B)

Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran; Department of Immunology, School of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran. Electronic address: baradaranb@tbzmed.ac.ir.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH